EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease

Keii To iD, Kosuke Okada, Takahisa Watahiki, Hideo Suzuki, Kiichiro Tsuchiya, Katsutoshi Tokushige, Masakazu Yamamoto, Shun-Ichi Ariizumi, Junichi Shoda

Cancer Medicine · 2023

DOI: 10.1002/cam4.6538 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, 2023. Verfasst von Keii To und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan. Hauptthemen laut MEDLINE: Non-alcoholic Fatty Liver Disease, Carcinoma, Hepatocellular, Liver Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The nuclear factor E2‐related factor 2–Kelch‐like Ech‐associated protein (NRF2–KEAP1) pathway is a major cellular defense mechanism against oxidative stress. However, the role of NRF2–KEAP1 signaling in the development of chronic liver disease remains unclear.

Methods

Clinical liver specimens from 50 hepatocellular carcinoma (HCC) developed from non‐alcoholic steatohepatitis (NASH), 49 HCCs developed from chronic viral hepatitis C (CHc), and 48 liver metastases of colorectal cancer (CRC) from both tumorous and non‐tumorous areas were collected during hepatic resection surgery. They were evaluated by immunohistochemical analyses of hematoxylin–eosin, Masson's trichrome, NRF2, and KEAP1, and compared with clinicopathological information.

Results

Hepatic inflammation and fibrosis were more severe in the low‐intensity NRF2 group than in the high‐intensity NRF2 group both between CRC and NASH (Low vs. High: inflammation; p = 0.003, fibrosis; p = 0.014), and between CRC and CHc (Low vs. High: inflammation; p = 0.031, fibrosis; p = 0.011), which could indicate that NRF2 expression in cytosol of hepatocytes was inversely correlated with liver inflammation and fibrosis in non‐tumorous areas. The dense staining of NRF2 in the nuclei of non‐tumor hepatocytes positively correlated with liver inflammation (CRC and NASH; R = 0.451, p < 0.001, CRC and CHc; R = 0.502, p < 0.001) and fibrosis (CRC and NASH; R = 0.566, p < 0.001, CRC and CHc; R = 0.548, p < 0.001) in both NASH and CHc, and was inversely correlated with hepatic spare ability features such as platelet count ( R = −0.253, p = 0.002) and prothrombin time ( R = −0.206, p = 0.012). However, KEAP1 expression was not correlated with NRF2 expression levels and nuclear staining intensity.

Conclusions

Nuclear translocation of NRF2 was correlated with the magnitude of liver inflammation and fibrosis in chronic liver disease. These results suggest that NRF2 plays a protective role in the development of chronic liver diseases such as NASH and CHc.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Non-alcoholic Fatty Liver DiseaseCarcinoma, HepatocellularLiver NeoplasmsHumansKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2LiverFibrosisInflammationLiver Cirrhosis

Stichwörter der Autor:innen

KEAP1NASHNRF2chronic liver diseasehepatocellular carcinoma

Substanzen

Kelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2

Autor:innen und Institutionen

  • Department of Gastroenterology, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Doctoral Program in Medical Sciences, Graduate School of Comprehensive Human Sciences, University of Tsukuba, Ibaraki, Japan.
  • Division of Medical Sciences, Institute of Medicine, University of Tsukuba, Ibaraki, Japan.
  • Institute of Gastroenterology and Internal Medicine, Tokyo Women's Medical University, Tokyo, Japan.
  • Department of Surgery, Institute of Gastroenterology, Tokyo Women's Medical University, Tokyo, Japan.

ORCID-Profile: Keii To

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

To, K., Okada, K., Watahiki, T., Suzuki, H., Tsuchiya, K., Tokushige, K., Yamamoto, M., Ariizumi, S. I., & Shoda, J. (2023). Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease. Cancer Medicine. https://doi.org/10.1002/cam4.6538

Vancouver

To K, Okada K, Watahiki T, Suzuki H, Tsuchiya K, Tokushige K, et al. Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease. Cancer Medicine. 2023. doi:10.1002/cam4.6538

BibTeX
@article{To2023,
  author = {To, Keii and Okada, Kosuke and Watahiki, Takahisa and Suzuki, Hideo and Tsuchiya, Kiichiro and Tokushige, Katsutoshi and Yamamoto, Masakazu and Ariizumi, Shun-Ichi and Shoda, Junichi},
  title = {Immunohistochemical expression of NRF2 is correlated with the magnitude of inflammation and fibrosis in chronic liver disease},
  journal = {Cancer Medicine},
  year = {2023},
  doi = {10.1002/cam4.6538}
}
Kostenlos starten →